.

LPL - DIKSHA LABORATORY

SERVICES
DIKSHA LABORATORY
SERVICES6, KARGUWA ROA D,
GATE NO-2, PIN CODE NO :

Name : Mrs. ANKITA SRIVASTAV Collected : 8/11/2014 12:40:00PM

Received : 8/11/2014 12:40:25PM
Lab No. : 206577175 Age: 31 Years Gender: Female Reported : 9/11/2014 1:21:45PM
A/c Status : P Ref By : SOMANI VERMA Report Status : Final

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD 6.40 % <6.40

(Boronate Affinity)

Note : 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient
who is recently under good control may still have a high concentration of HbA1c. Converse is true
for a diabetic previously under good control but now poorly controlled .

2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life
expectancy and no significant cardiovascular disease. In patients with significant complications of
diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may
not be appropriate.

Comments
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better
indicator of long term glycemic control as compared to blood and urinary glucose determinations.

ADA criteria for correlation between HbA1c & Mean plasma glucose levels
---------------------------------------
| HbA1c(%) | Mean Plasma Glucose (mg/dL)|
|----------|----------------------------|
| 6 | 126 |
|----------|----------------------------|
| 7 | 154 |
|----------|----------------------------|
| 8 | 183 |
|----------|----------------------------|
| 9 | 212 |
|----------|----------------------------|
| 10 | 240 |
|----------|----------------------------|
| 11 | 269 |
|----------|----------------------------|
| 12 | 298 |
---------------------------------------

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 5)

Page 1 of 6
.

LPL - DIKSHA LABORATORY

SERVICES
DIKSHA LABORATORY
SERVICES6, KARGUWA ROA D,
GATE NO-2, PIN CODE NO :

Name : Mrs. ANKITA SRIVASTAV Collected : 8/11/2014 12:40:00PM

Received : 8/11/2014 12:40:25PM
Lab No. : 206577175 Age: 31 Years Gender: Female Reported : 9/11/2014 1:21:48PM
A/c Status : P Ref By : SOMANI VERMA Report Status : Final

Test Name Results Units Bio. Ref. Interval

ESTRADIOL (E2), SERUM @ 40.26 pg/mL
(CLIA)
Interpretation

--------------------------------------------------------
| MENSTRUAL PHASE | REFERENCE RANGE IN pg/mL |
|-----------------------|--------------------------------|
| Follicular | 19.5 - 144.2 |
|-----------------------|--------------------------------|
| Mid cycle | 63.9 - 356.7 |
|-----------------------|--------------------------------|
| Luteal | 55.8 - 214.2 |
|-----------------------|--------------------------------|
| Post Menopausal | <32.2 |
--------------------------------------------------------

Clinical Use
· Determine estrogen status in women
· Monitor follicular development during induction of ovulation
· Assess estrogen production in males

Increased Levels
· Precocious puberty (female)
· Male gynecomastia
· Liver disease
· Ovarian tumors
· Adrenal feminizing tumors

Decreased Level
· Oral contraceptives
· Ovarian failure

FSH; FOLLICLE STIMULATING HORMONE, SERUM 5.61 mIU/mL

(Chemiluminesent Immunoassay)
Interpretation
--------------------------------------------------------------
| REFERENCE GROUP | REFERENCE RANGE IN mIU/mL |
|----------------------------------|---------------------------|
| Adult Females | |
| Follicular | 2.50 - 10.20 |
| Mid Cycle Peak | 3.40 - 33.40 |
| Luteal Phase | 1.50 - 9.10 |
| Post Menopausal | 23.00 - 116.30 |
| Pregnant | < 0.30 |

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 2 of 6
.

LPL - DIKSHA LABORATORY

SERVICES
DIKSHA LABORATORY
SERVICES6, KARGUWA ROA D,
GATE NO-2, PIN CODE NO :

Name : Mrs. ANKITA SRIVASTAV Collected : 8/11/2014 12:40:00PM

Received : 8/11/2014 12:40:25PM
Lab No. : 206577175 Age: 31 Years Gender: Female Reported : 9/11/2014 1:21:48PM
A/c Status : P Ref By : SOMANI VERMA Report Status : Final

Test Name Results Units Bio. Ref. Interval

--------------------------------------------------------------

Clinical Use
· Diagnosis of gonadal function disorders
· Management and treatment of infertility in both genders

Increased levels
· Primary hypogonadism
· Gonadotropin secreting pituitary tumors
· Menopause

Decreased levels
· Hypothalamic GnRH deficiency
· Pituitary FSH deficiency
· Ectopic steroid hormone production

LH; LUTEINISING HORMONE, SERUM 3.09 mIU/mL

(Chemiluminescent Immunoassay)
Interpretation
--------------------------------------------------------------
| REFERENCE GROUP | REFERENCE RANGE IN mIU/mL |
|----------------------------------|---------------------------|
| Adult Females | |
| Follicular | 1.90 - 12.50 |
| Mid Cycle Peak | 8.70 - 76.30 |
| Luteal Phase | 0.50 - 16.90 |
| Post Menopausal | 15.90 - 54.00 |
| Pregnant | 0.10 - 1.50 |
| Oral Contraceptives | 0.70 - 5.60 |
--------------------------------------------------------------

Clinical Use
· Diagnosis of gonadal function disorders
· Diagnosis of pituitary disorders

Increased levels
· Primary hypogonadism
· Gonadotropin secreting pituitary tumors
· Menopause
· Luteal phase of menstrual cycle
· Polycystic ovarian disease

Decreased levels
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 3 of 6
.

LPL - DIKSHA LABORATORY

SERVICES
DIKSHA LABORATORY
SERVICES6, KARGUWA ROA D,
GATE NO-2, PIN CODE NO :

Name : Mrs. ANKITA SRIVASTAV Collected : 8/11/2014 12:40:00PM

Received : 8/11/2014 12:40:25PM
Lab No. : 206577175 Age: 31 Years Gender: Female Reported : 9/11/2014 1:21:48PM
A/c Status : P Ref By : SOMANI VERMA Report Status : Final

Test Name Results Units Bio. Ref. Interval

· Hypothalamic GnRH deficiency
· Pituitary LH deficiency
· Ectopic steroid hormone production
· GnRH analog treatment
PROLACTIN, SERUM 24.33 ng/mL
(Chemiluminescent Immunoassay)
Interpretation
--------------------------------------------------------------
| REFERENCE GROUP | REFERENCE RANGE IN ng/mL |
|----------------------------------|---------------------------|
| Adult Females | |
| Non Pregnant | 2.80-29.20 |
| Pregnant | 9.70-208.50 |
| Post Menopausal | 1.80-20.30 |
--------------------------------------------------------------

Note
1. Since prolactin is secreted in a pulsatile manner and is also influenced by a variety of physiologic
stimuli, it is recommended to test 3 specimens at 20-30 minute intervals after pooling.
2. Major circulating form of Prolactin is a nonglycosylated monomer, but several forms of Prolactin linked
with immunoglobulin occur which can give falsely high Prolactin results.
3. Macroprolactin assay is recommended if prolactin levels are elevated, but signs and symptoms of
hyperprolactinemia are absent or pituitary imaging studies are normal

Clinical Use
· Diagnosis & management of pituitary adenomas
· Differential diagnosis of male & female hypogonadism

Increased Levels
· Physiologic: Sleep, stress, postprandially, pain, coitus, pregnancy, nipple stimulation or nursing
· Systemic disorders: Chest wall or thoracic spinal cord lesions, Primary / Secondary hypothyroidism,
Adrenal insufficiency, Chronic renal failure, Cirrhosis
· Medications:
§ Psychiatric medications like Phenothiazine, Haloperidol, Risperidone, Domperidone,
Fluoexetine, Amitriptylene, MAO inhibitors etc.,
§ Antihypertensives: Alphamethyldopa, Reserpine, Verapamil
§ Opiates: Heroin, Methadone, Morphine, Apomorphine
§ Estrogens
§ Oral contraceptives
§ Cimetidine / Ranitidine
· Prolactin secreting pituitary tumors: Prolactinoma, Acromegaly
· Miscellaneous: Polycystic ovarian disease, Epileptic seizures, Ectopic secretion of prolactin by
non-pituitary tumors, pressure / transaction of pituitary stalk, macroprolactinemia
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 4 of 6
.

LPL - DIKSHA LABORATORY

SERVICES
DIKSHA LABORATORY
SERVICES6, KARGUWA ROA D,
GATE NO-2, PIN CODE NO :

Name : Mrs. ANKITA SRIVASTAV Collected : 8/11/2014 12:40:00PM

Received : 8/11/2014 12:40:25PM
Lab No. : 206577175 Age: 31 Years Gender: Female Reported : 9/11/2014 1:21:48PM
A/c Status : P Ref By : SOMANI VERMA Report Status : Final

Test Name Results Units Bio. Ref. Interval

· Idiopathic

Decreased levels
· Pituitary deficiency: Pituitary necrosis / infarction
· Bromocriptine administration
· Pseudohypoparathyroidism

T4 FREE & TSH ULTRASENSITIVE

(CLIA)

T4, Free; FT4 @ 0.90 ng/dL 0.89 - 1.76

TSH, Ultrasensitive @ 2.501 uIU/mL 0.550 - 4.780

Reference Ranges for pregnancy

-----------------------------------------------------
| PREGNANCY |REFERENCE RANGE | REFERENCE |
| |for TSH in uIU/mL | RANGE for FT4 |
| |(As per American | in ng/dL |
| |Thyroid Association)| |
|-------------|--------------------|------------------|
|1st Trimester| 0.100 - 2.500 | 0.70 -2.00 |
|-------------|--------------------|------------------|
|2st Trimester| 0.200 - 3.000 | 0.50 -1.60 |
|-------------|--------------------|------------------|
|3st Trimester| 0.300 - 3.000 | 0.50 -1.60 |
-----------------------------------------------------
Note:
TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum
between 6-10 pm. The variation is of the order of 50%. hence time of the day has influence on the measured
serum TSH concentrations.

Clinical Use
· Primary Hypothyroidism
· Hyperthyroidism
· Hypothalamic - Pituitary hypothyroidism
· Inappropriate TSH secretion
· Nonthyroidal illness
· Autoimmune thyroid disease
· Pregnancy associated thyroid disorders
· Thyroid dysfunction in infancy and early childhood.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 5 of 6
.

LPL - DIKSHA LABORATORY

SERVICES
DIKSHA LABORATORY
SERVICES6, KARGUWA ROA D,
GATE NO-2, PIN CODE NO :

Name : Mrs. ANKITA SRIVASTAV Collected : 8/11/2014 12:40:00PM

Received : 8/11/2014 12:40:25PM
Lab No. : 206577175 Age: 31 Years Gender: Female Reported : 9/11/2014 1:21:48PM
A/c Status : P Ref By : SOMANI VERMA Report Status : Final

Test Name Results Units Bio. Ref. Interval

Dr Onjal Taywade Dr. Sachin Singhal

MD (Biochemistry) MBBS, MD(PATH)
Consultant Biochemist Chief of Pathology

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 6 of 6